These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 18434152)

  • 21. Second generation of BACE-1 inhibitors part 2: Optimisation of the non-prime side substituent.
    Charrier N; Clarke B; Demont E; Dingwall C; Dunsdon R; Hawkins J; Hubbard J; Hussain I; Maile G; Matico R; Mosley J; Naylor A; O'Brien A; Redshaw S; Rowland P; Soleil V; Smith KJ; Sweitzer S; Theobald P; Vesey D; Walter DS; Wayne G
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3669-73. PubMed ID: 19477642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BACE-1 inhibitors part 3: identification of hydroxy ethylamines (HEAs) with nanomolar potency in cells.
    Beswick P; Charrier N; Clarke B; Demont E; Dingwall C; Dunsdon R; Faller A; Gleave R; Hawkins J; Hussain I; Johnson CN; MacPherson D; Maile G; Matico R; Milner P; Mosley J; Naylor A; O'Brien A; Redshaw S; Riddell D; Rowland P; Skidmore J; Soleil V; Smith KJ; Stanway S; Stemp G; Stuart A; Sweitzer S; Theobald P; Vesey D; Walter DS; Ward J; Wayne G
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1022-6. PubMed ID: 18171615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: prime side chromane-containing inhibitors.
    Ng RA; Sun M; Bowers S; Hom RK; Probst GD; John V; Fang LY; Maillard M; Gailunas A; Brogley L; Neitz RJ; Tung JS; Pleiss MA; Konradi AW; Sham HL; Dappen MS; Adler M; Yao N; Zmolek W; Nakamura D; Quinn KP; Sauer JM; Bova MP; Ruslim L; Artis DR; Yednock TA
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4674-9. PubMed ID: 23856050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BACE-1 inhibitors part 1: identification of novel hydroxy ethylamines (HEAs).
    Clarke B; Demont E; Dingwall C; Dunsdon R; Faller A; Hawkins J; Hussain I; MacPherson D; Maile G; Matico R; Milner P; Mosley J; Naylor A; O'Brien A; Redshaw S; Riddell D; Rowland P; Soleil V; Smith KJ; Stanway S; Stemp G; Sweitzer S; Theobald P; Vesey D; Walter DS; Ward J; Wayne G
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1011-6. PubMed ID: 18171614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-guided design and synthesis of P1' position 1-phenylcycloalkylamine-derived pentapeptidic BACE1 inhibitors.
    Tagad HD; Hamada Y; Nguyen JT; Hidaka K; Hamada T; Sohma Y; Kimura T; Kiso Y
    Bioorg Med Chem; 2011 Sep; 19(17):5238-46. PubMed ID: 21803585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of cyclic sulfone hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure-based design and in vivo reduction of amyloid β-peptides.
    Rueeger H; Lueoend R; Rogel O; Rondeau JM; Möbitz H; Machauer R; Jacobson L; Staufenbiel M; Desrayaud S; Neumann U
    J Med Chem; 2012 Apr; 55(7):3364-86. PubMed ID: 22380629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3,4-Fused cyclohexyl sulfones as gamma-secretase inhibitors.
    Shaw D; Best J; Dinnell K; Nadin A; Shearman M; Pattison C; Peachey J; Reilly M; Williams B; Wrigley J; Harrison T
    Bioorg Med Chem Lett; 2006 Jun; 16(11):3073-7. PubMed ID: 16617016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. alpha-Naphthylaminopropan-2-ol Derivatives as BACE1 Inhibitors.
    Asso V; Ghilardi E; Bertini S; Digiacomo M; Granchi C; Minutolo F; Rapposelli S; Bortolato A; Moro S; Macchia M
    ChemMedChem; 2008 Oct; 3(10):1530-4. PubMed ID: 18781572
    [No Abstract]   [Full Text] [Related]  

  • 29. Design and synthesis of cell potent BACE-1 inhibitors: structure-activity relationship of P1' substituents.
    Sealy JM; Truong AP; Tso L; Probst GD; Aquino J; Hom RK; Jagodzinska BM; Dressen D; Wone DW; Brogley L; John V; Tung JS; Pleiss MA; Tucker JA; Konradi AW; Dappen MS; Toth G; Pan H; Ruslim L; Miller J; Bova MP; Sinha S; Quinn KP; Sauer JM
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6386-91. PubMed ID: 19811916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of α-phenylnorstatine and α-benzylnorstatine as transition state isostere motifs in the search for new BACE-1 inhibitors.
    Wångsell F; Nordeman P; Sävmarker J; Emanuelsson R; Jansson K; Lindberg J; Rosenquist S; Samuelsson B; Larhed M
    Bioorg Med Chem; 2011 Jan; 19(1):145-55. PubMed ID: 21183353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.
    Bowers S; Xu YZ; Yuan S; Probst GD; Hom RK; Chan W; Konradi AW; Sham HL; Zhu YL; Beroza P; Pan H; Brecht E; Yao N; Lougheed J; Tam D; Ren Z; Ruslim L; Bova MP; Artis DR
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2181-6. PubMed ID: 23465612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of potent hydroxyethylamine (HEA) BACE-1 inhibitors carrying prime side 4,5,6,7-tetrahydrobenzazole and 4,5,6,7-tetrahydropyridinoazole templates.
    Sund C; Belda O; Borkakoti N; Lindberg J; Derbyshire D; Vrang L; Hamelink E; Åhgren C; Woestenenk E; Wikström K; Eneroth A; Lindström E; Kalayanov G
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6721-7. PubMed ID: 23010268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereochemical analysis of (hydroxyethyl)urea peptidomimetic inhibitors of gamma-secretase.
    Bakshi P; Wolfe MS
    J Med Chem; 2004 Dec; 47(26):6485-9. PubMed ID: 15588083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of potent BACE-1 inhibitors containing a new hydroxyethylene (HE) scaffold: exploration of P1' alkoxy residues and an aminoethylene (AE) central core.
    Björklund C; Adolfsson H; Jansson K; Lindberg J; Vrang L; Hallberg A; Rosenquist S; Samuelsson B
    Bioorg Med Chem; 2010 Feb; 18(4):1711-23. PubMed ID: 20122837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly potent macrocyclic BACE-1 inhibitors incorporating a hydroxyethylamine core: design, synthesis and X-ray crystal structures of enzyme inhibitor complexes.
    Sandgren V; Agback T; Johansson PO; Lindberg J; Kvarnström I; Samuelsson B; Belda O; Dahlgren A
    Bioorg Med Chem; 2012 Jul; 20(14):4377-89. PubMed ID: 22698785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potent and selective isophthalamide S2 hydroxyethylamine inhibitors of BACE1.
    Kortum SW; Benson TE; Bienkowski MJ; Emmons TL; Prince DB; Paddock DJ; Tomasselli AG; Moon JB; LaBorde A; TenBrink RE
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3378-83. PubMed ID: 17434734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.
    Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni SS; Xu X; Chang W; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J
    J Med Chem; 2007 May; 50(10):2399-407. PubMed ID: 17432843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phe*-Ala-based pentapeptide mimetics are BACE inhibitors: P2 and P3 SAR.
    Lamar J; Hu J; Bueno AB; Yang HC; Guo D; Copp JD; McGee J; Gitter B; Timm D; May P; McCarthy J; Chen SH
    Bioorg Med Chem Lett; 2004 Jan; 14(1):239-43. PubMed ID: 14684335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and docking studies of Hydroxyethylamine and Hydroxyethylsulfide BACE-1 inhibitors.
    Rizzi L; Vaiana N; Sagui F; Genesio E; Pilli E; Porcari V; Romeo S
    Protein Pept Lett; 2009; 16(1):86-90. PubMed ID: 19149679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of Hydroxyethylamine Transition State Isosteres as Aspartic Protease Inhibitors by Exploiting Conformational Preferences.
    Bueno AB; Agejas J; Broughton H; Dally R; Durham TB; Espinosa JF; González R; Hahn PJ; Marcos A; Rodríguez R; Sanz G; Soriano JF; Timm D; Vidal P; Yang HC; McCarthy JR
    J Med Chem; 2017 Dec; 60(23):9807-9820. PubMed ID: 29088532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.